New Insights into Down Syndrome Pathogenesis: C21orf80's Role in Normal Development

The study published in the journal Genomics on September 26, 2004, by O. Menzel and colleagues at the University of Geneva provides new insights into the pathogenesis of Down syndrome, a genetic disorder caused by an extra copy of chromosome 21. The researchers isolated and characterized the C21orf80 gene, a potential novel protein O-fucosyltransferase, and demonstrated that its Caenorhabditis elegans ortholog, pad-2, is required for normal development.

Key Takeaways:

• The C21orf80 gene, a potential novel protein O-fucosyltransferase, has been isolated and characterized by the researchers.
• The Caenorhabditis elegans ortholog of C21orf80, pad-2, is required for normal development, and its disruption leads to failure in undergoing normal morphogenesis.
• The overexpression of pad-2 in transgenic worms results in severe body malformations and abnormal neuronal development.
• These findings suggest a potential role for C21orf80 in the pathogenesis of Down syndrome.
• The researchers used RNA interference (RNAi) and overexpression experiments to study the biological role of C21orf80 and its potential role in DS.
• The study highlights the importance of understanding the functional role of genes on chromosome 21 in Down syndrome.

Statistics:

• The study reported that transient expression of tagged C21orf80 proteins suggests a primary intracellular localization in the Golgi apparatus.
• RNAi experiments showed that pad-2(RNAi) embryos failed to undergo normal morphogenesis.
• Transgenic worms with elevated dosage of pad-2 displayed severe body malformations and abnormal neuronal development in 100% of cases.

Sources:

• Menzel, O., et al. "The Caenorhabditis elegans ortholog of C21orf80, a potential new protein O-fucosyltransferase, is required for normal development." Genomics 84.2 (2004): 320-330.
• Academic Press Inc. Elsevier Science, publisher of the journal Genomics.